Poliovirus Receptor Protein (PVR) (C-Term, Extracellular Domain)
-
- Target See all Poliovirus Receptor (PVR) Proteins
- Poliovirus Receptor (PVR)
- Protein Type
- Recombinant
- Biological Activity
- Active
- Protein Characteristics
- C-Term, Extracellular Domain
-
Origin
- Rat
-
Source
- HEK-293T Cells
- Specificity
- Optimized DNA sequence encoding extracellular domain of rat PVR (CD155) including a C-terminal 6His tag was expressed in HEK293 cells.
- Characteristics
- Recombinant rat PVR (CD155) is a monomer protein consisting of 329 amino acid residue subunits, due to glycosylation migrates as an approximately 55-60 kDa protein on SDS-PAGE.
- Purity
- > 95 %, as determined by SDS-PAGE and HPLC
- Sterility
- 0.2 μm filtered
- Endotoxin Level
- Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).
- Top Product
- Discover our top product PVR Protein
-
-
- Comment
-
The biological activity of rat PVR was measured by the binding ability of immobilized recombinant rat CD155 (20 µg/mL100 µL/well ) to mouse CD226 (linear ranger of 6 - 200 ng/mL) in a functional ELISA assay.
- Restrictions
- For Research Use only
-
- Buffer
- PBS solution, pH7.2
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- The lyophilized protein is stable for at least years from date of receipt at -20 °C. Upon reconstitution, this protein can be stored in working aliquots at - 8 °C for one month, or at -20 °C for six months, with a carrier protein without detectable loss of activity.
- Expiry Date
- 12-24 months
-
- Target
- Poliovirus Receptor (PVR)
- Alternative Name
- CD155 (PVR Products)
- Synonyms
- PVR Protein, CD155 Protein, HVED Protein, NECL5 Protein, Necl-5 Protein, PVS Protein, TAGE4 Protein, 3830421F03Rik Protein, D7Ertd458e Protein, Taa1 Protein, Tage4 Protein, mE4 Protein, necl-5 Protein, poliovirus receptor Protein, PVR Protein, Pvr Protein
- UniProt
- Q5U334
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
-